Section 337 investigations by the U.S. International Trade Commission (ITC) target imported articles rather than solely the companies that manufacture them. This means Canadian manufacturers without U.S. offices, employees, or bank accounts remain exposed if their products cross the U.S. border, whether shipped directly or through U.S. distributors. Unlike district court litigation, where personal jurisdiction or venue defenses may be available, the ITC’s jurisdiction focuses on the imported goods themselves, making such defenses ineffective in excluding products from investigation.
The ITC can issue general exclusion orders that block infringing products regardless of the importer’s identity. These orders are typically reserved for cases involving a pattern of violations where the source of infringing goods is difficult to identify. Consequently, Canadian companies not named in a case may nonetheless find their products barred under such orders, as demonstrated by recent investigations involving Epson ink cartridges (337-TA-1452) and ARPC RV refrigerators (337-TA-1453).
In addition to exclusion orders, the ITC may issue cease-and-desist orders preventing respondents from selling inventory already within the United States, which is critical for companies maintaining U.S. warehouses or consignment stock. While the ITC does not award monetary damages, its border enforcement remedies can effectively shut infringing product lines out of the U.S. market, even when potential damages in federal court would be limited.
Section 337 investigations are among the fastest patent enforcement proceedings in the U.S., typically advancing to evidentiary hearings within approximately one year and concluding within 16 to 18 months from institution. Respondents generally have 20 days from service of the complaint and notice of investigation to file their responses. Canadian companies should prepare for rapid discovery, including production of engineering and sales records located in Canada, as the ITC expects comprehensive and timely compliance regardless of geographic location.
Design-around strategies are viable but time-sensitive. Respondents can seek Customs rulings that redesigned products fall outside exclusion orders, but such redesigns must be documented and ready for importation promptly to avoid market disruption following adverse rulings. The ITC’s 60-day Presidential review period after a final determination is a limited window during which products may enter the U.S. only under bond, not a means to circumvent exclusion orders.
Parallel district court litigation and USPTO inter partes review (IPR) proceedings proceed independently of ITC investigations. District court cases are often stayed at the respondent’s request during ITC proceedings, while the USPTO may exercise discretion in instituting IPRs. The ITC typically does not delay its process to await outcomes in these forums.
Beyond defense, Canadian companies owning U.S. patents can initiate Section 337 complaints to block infringing imports. However, they must satisfy the domestic industry requirement, demonstrating significant U.S. investment in plant and equipment, labor or capital, or substantial exploitation of the patent through engineering, research and development, or licensing within the United States. Historically, this requirement excluded many foreign manufacturers whose U.S. presence was limited to sales and marketing.
The Federal Circuit’s March 5, 2025 decision in Lashify, Inc. v. ITC marked a pivotal change. The court held that U.S. expenditures on sales, marketing, warehousing, quality control, and distribution qualify as “labor and capital” for the domestic industry test, even if manufacturing occurs abroad. Lashify’s products were manufactured overseas, yet the ruling recognized the significance of U.S.-based commercial activities in meeting the economic prong of the domestic industry requirement.
For Canadian manufacturers operating U.S. sales teams, warehouses, or distribution and service networks, Lashify opens the ITC as a practical enforcement venue. Nonetheless, the investment must be substantial and physically located in the United States. The technical prong—requiring a U.S. product that practices the patent—is distinct and fact-specific; Lashify itself failed to meet this prong for certain patents. Careful analysis is essential before assuming the ITC forum is accessible.
In summary, Canadian companies must recognize that ITC Section 337 investigations can reach their products at the border regardless of their U.S. presence. The remedies available can effectively exclude infringing imports, and the procedural pace demands early and strategic preparation. The Lashify decision further empowers Canadian patentees with meaningful U.S. commercial operations to proactively enforce their patent rights at the ITC, expanding the scope of potential relief beyond traditional district court litigation.
Canadian Manufacturers Navigate U.S. ITC Section 337 Investigations: Defense and Enforcement Post-Lashify Canadian manufacturers remain subject to U.S. International Trade Commission (ITC) Section 337 investigations when their products enter the U.S. market, regardless of their physical presence in the United States. This a... Read the full IIPLA article: https://iipla.org/news/canadian-manufacturers-navigate-u-s-itc-section-337-investigations-defense-and-enforcement-post-lashify